Medications

FDA panel narrowly sides against experimental ALS drug

Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.

Medications

Psoriasis treatments can be life-changing

If you suffer from psoriasis, vibrant, clear skin is no longer out of reach. According to Rush dermatologists, new innovative treatments can help you put your best face forward.

Oncology & Cancer

Patient economic burden for cancer care $21.1 billon in 2019

(HealthDay)—Patient economic burden associated with cancer care was projected to be $21.1 billion in 2019, according to a report published online Oct. 26 in the Journal of the National Cancer Institute.

page 12 from 40